Kinetic spectrophotometric method for the determination of perindopril erbumine in pure and commercial dosage forms
Open Access
- 1 February 2017
- journal article
- Published by Elsevier BV in Arabian Journal of Chemistry
- Vol. 10, S831-S838
- https://doi.org/10.1016/j.arabjc.2012.12.017
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- DEVELOPMENT OF SPECTROPHOTOMETRIC METHOD FOR THE DETERMINATION OF PERINDOPRIL ERBUMINE IN PHARMACEUTICAL FORMULATIONS USING 2, 4 DINITROFLUOROBENZENEJournal of the Chilean Chemical Society, 2012
- Quantitative analysis of perindopril erbumine in pharmaceutical preparations by spectrophotometry via ternary complex formation with Zn(II) and eosin and charge transfer complexation with iodineJournal of Spectroscopy, 2011
- Evaluation of impurities level of perindopril tert-butylamine in tabletsJournal of Pharmaceutical and Biomedical Analysis, 2007
- First LC–MS/MS electrospray ionization validated method for the quantification of perindopril and its metabolite perindoprilat in human plasma and its application to bioequivalence studyJournal of Chromatography B, 2006
- High‐throughput quantification of perindopril in human plasma by liquid chromatography/tandem mass spectrometry: application to a bioequivalence studyRapid Communications in Mass Spectrometry, 2006
- Utility of certain π-acceptors for the spectrophotometric determination of perindoprilJournal of Pharmaceutical and Biomedical Analysis, 1998
- Derivatization-GAS Chromatographic Determination of PerindoprilAnalytical Letters, 1996
- Reappraisal of Hypothesis Testing for Method Validation: Detection of Systematic Error by Comparing the Means of Two Methods or of Two LaboratoriesAnalytical Chemistry, 1995
- The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patientsEuropean Journal of Clinical Pharmacology, 1987
- Inhibition of Angiotensin I-Converting Enzyme with S 9490Journal of Cardiovascular Pharmacology, 1984